Figure 2.
Urinary levels of human epididymis secretory protein 4 (HE4). (A) Monocyte chemotactic protein-1 (MCP-1) (B), and liver-type fatty acid-binding protein (L-FABP) (C) in the non-AKI group and TAC–AKI group immediately before tacrolimus administration on Postoperative Day 1. There were 20 measurements in the non-AKI group (20 subjects) and six measurements in the TAC–AKI group (six subjects). Urinary levels of HE4 (D), MCP-1 (E), and L-FABP (F) in the non-AKI and TAC–AKI groups during tacrolimus therapy (either Postoperative Day 7 or 14). There were 40 measurements in the non-AKI group (20 subjects) and seven measurements in the TAC–AKI group (six subjects).